Cardiometabolic disorders are a significant source of morbidity and mortality in psoriatic disease. The presence of traditional cardiovascular (CV) risk factors, such as hypercholesterolemia, metabolic syndrome, and obesity, contributes to the elevated risk of CV disease in patients with psoriasis....

Heart failure (HF), a major challenge in cardiovascular medicine, presents significant morbidity and mortality despite advances in treatment. Mineralocorticoid receptor antagonists (MRAs) have emerged as a cornerstone of therapy, demonstrating substantial benefits in reducing hospitalization, improving survival, and enhancing quality...

This video-based program is designed to provide education on identifying hypercortisolism using a unique format in which the potential consequences of a delayed diagnosis will be revealed using patient-clinician interaction videos. The faculty will focus on recognizing subclinical or atypical...

The BURST CME™ format is an online, on-demand video program designed to deliver concise, modular education. In these modules, Hanford Yau, MD, and Stephen J. Greene, MD, review the relationship between hypercortisolism and hypertension, identifying patients with resistant hypertension who...

This activity is a video-based program in which 2 experts discuss the etiology of atherosclerotic cardiovascular disease (ASCVD) and the management of hyperlipidemia to reduce risk. Expert faculty focus on the role of elevated lipids in the development of ASCVD...

The underlying pathophysiology of pulmonary arterial hypertension (PAH), a variant of pulmonary hypertension, originates in the pulmonary vasculature. Due to the rarity of PAH, few pediatric patients receive specialized therapy. In this video-based program, a pediatric pulmonologist and a pediatric...

Despite robust evidence supporting aggressive LDL-cholesterol reduction for the prevention of atherosclerotic cardiovascular disease (ASCVD), substantial gaps persist between guideline recommendations and real-world treatment intensification. Many high-risk and very high-risk patients fail to achieve recommended LDL-C thresholds, leaving them vulnerable...